Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Expert Review of Clinical Immunology
|
January 24, 2014
Type I IFN signature in primary Sjögren's syndrome patients
Zana Brkic, Marjan A Versnel
Frontiers in Immunology
|
June 29, 2026
Type I interferon pathway activation in connective tissue disease associated interstitial lung disease
Tobias M Defesche, Thomas Koudstaal, Marjan A Versnel, et al.
Rheumatology (Oxford, England)
|
October 31, 2014
Prevalence of distal renal tubular acidosis in primary Sjögren's syndrome
Tim Both, Ewout J Hoorn, Robert Zietse, et al.
Annals of the Rheumatic Diseases
|
June 28, 2012
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression
Zana Brkic, Naomi I Maria, Cornelia G van Helden-Meeuwsen, et al.
Annals of the Rheumatic Diseases
|
July 9, 2013
MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome
Naomi I Maria, Zana Brkic, Matti Waris, et al.
RMD Open
|
May 9, 2025
Amlexanox inhibits production of type I interferon and suppresses B cell differentiation <i>in vitro</i>: a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases
Albin Björk, Mohamed Javad Wahadat, Maria Sánchez-Blázquez, et al.
Rheumatology (Oxford, England)
|
September 10, 2021
Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren's syndrome
Erika Huijser, Jens Göpfert, Zana Brkic, et al.
Frontiers in Oncology
|
April 10, 2023
Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren's syndrome patients through immunogenetics
P Martijn Kolijn, Erika Huijser, M Javad Wahadat, et al.
Annals of the Rheumatic Diseases
|
September 28, 2016
Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome
Naomi I Maria, Eline C Steenwijk, Arne S IJpma, et al.
Journal of Translational Autoimmunity
|
February 3, 2021
Characteristics of COVID-19 infection and antibody formation in patients known at a tertiary immunology department
Niels A D Guchelaar, Jan A M van Laar, Maud A W Hermans, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Expert Review of Clinical Immunology
|
January 24, 2014
Type I IFN signature in primary Sjögren's syndrome patients
Zana Brkic, Marjan A Versnel
Frontiers in Immunology
|
June 29, 2026
Type I interferon pathway activation in connective tissue disease associated interstitial lung disease
Tobias M Defesche, Thomas Koudstaal, Marjan A Versnel, et al.
Rheumatology (Oxford, England)
|
October 31, 2014
Prevalence of distal renal tubular acidosis in primary Sjögren's syndrome
Tim Both, Ewout J Hoorn, Robert Zietse, et al.
Annals of the Rheumatic Diseases
|
June 28, 2012
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression
Zana Brkic, Naomi I Maria, Cornelia G van Helden-Meeuwsen, et al.
Annals of the Rheumatic Diseases
|
July 9, 2013
MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome
Naomi I Maria, Zana Brkic, Matti Waris, et al.
RMD Open
|
May 9, 2025
Amlexanox inhibits production of type I interferon and suppresses B cell differentiation <i>in vitro</i>: a possible therapeutic option for systemic lupus erythematosus and other systemic inflammatory diseases
Albin Björk, Mohamed Javad Wahadat, Maria Sánchez-Blázquez, et al.
Rheumatology (Oxford, England)
|
September 10, 2021
Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren's syndrome
Erika Huijser, Jens Göpfert, Zana Brkic, et al.
Frontiers in Oncology
|
April 10, 2023
Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren's syndrome patients through immunogenetics
P Martijn Kolijn, Erika Huijser, M Javad Wahadat, et al.
Annals of the Rheumatic Diseases
|
September 28, 2016
Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome
Naomi I Maria, Eline C Steenwijk, Arne S IJpma, et al.
Journal of Translational Autoimmunity
|
February 3, 2021
Characteristics of COVID-19 infection and antibody formation in patients known at a tertiary immunology department
Niels A D Guchelaar, Jan A M van Laar, Maud A W Hermans, et al.
Page
of 2